Clinical and pharmacological studies on liver diseases treated with kampo herbal medicine

American Journal of Chinese Medicine

Volumn 28, Issue 3-4, 2000, Pages 351-360

  Cyong, Jong Chol ^a   Kirn, Sun Min ^a   Iijima, Koji ^a   Kobayashi, Takao ^b   Furuya, Minoru ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; CYCLOOCTANE DERIVATIVE; GOMISIN A; HERBACEOUS AGENT; LIGNAN; PLANT EXTRACT; REN-SHEN-YANG-RONG-TANG; VIRUS RNA;

ADULT; AGED; ANIMAL; ARTICLE; BLOOD; CELL LINE; CHINESE MEDICINE; HEPATITIS C; HUMAN; LIVER DISEASE; LIVER FAILURE; MIDDLE AGED; MOUSE; REN SHEN YANG RONG TANG; TIME; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL LINE; CYCLOOCTANES; DIOXOLES; DRUGS, CHINESE HERBAL; HEPATITIS C, CHRONIC; HUMANS; LIGNANS; LIVER DISEASES; LIVER FAILURE; MEDICINE, KAMPO; MICE; MIDDLE AGED; PLANT EXTRACTS; RNA, VIRAL; TIME FACTORS;

EID: 0034572785     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/s0192415x00000416     Document Type: Article

References (9)

1. Arai, T., K. Hiromatsu, N. Kobayashi, M. Takano, H. Ishida, Y. Nimura, Y. Yoshikai. IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury. J. Immimot. 155: 5743-5749, 1995.
2. Gish, R.G. Future directions in the treatment of patients with chronic hepatitis C virus infection. Can. J. Gastroenterol. 13: 57-62, 1999.
3. Luo, J.C., S.J. Hwang, C.R. Lai, C.L. Lu, C.P. Li, S.H. Tsay, J.C. Wu, F.Y. Chang, S.D. Lee. Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in Taiwan. J. Gastroenterol. Hepatol. 13: 685-690, 1998.
4. Koda, A., Y. Ono, T. Nishiyori, H. Nagai, N. Matsuura, A. Mase and T. Matsuyama. Immunopharmalogical studies of wen-qing-yin, a Chinese blended medicine: effects on type IV allergic reactions and humoral antibody production. //;J. J. Imimmopharmac. 9:289-295,1987.
5. Iijima, K., H. Kiyohara, M. Tanaka, T. Matsumoto, J.C. Cyong and H. Yamada. Preventive effect of taraxasteryl acetate form Inula britannica subsp. japonica on experimental hepatitis in vivo. Planta Med. 61: 50-53, 1995.
6. Nomura, M., Y. Ohtaki, T. Hida, T. Aizawa, H. Wakita and K. Miyamoto. Inhibition of early 3-methyl-4-dimethylaminoazobenzene-induced hepatocarcinogenesis by gomisin A in rats. Anticancer Res. 14(5A): 1967-1971, 1994.
7. Shiota, G., S. Yamada and H. Kawasaki. Rapid induction of hepatocyte growth factor mRNA after administration of gomisin A, a lignan component of shizandra fruits. Res. Commun. Mol. Patliol. Pharmacol. 94: 141-146, 1996.
8. Tajiri, H., K. Kozaiwa, Y. Ozaki, K. Miki, K. Shimuzu and S. Okada. Effect of Sho-saiko-to on HBeAg clearance in children with chronic hepatitis B virus infection and with sustained liver disease. Am. J. Chin. Med. 19: 121-129, 1991.
9. Shimizu, Y.K., A. Iwamoto, M. Hijikata, R.H. Purcell and H. Yoshikura. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc. Nat. Acad. Sei. 89: 5477-5481,1992.